/   Home   /   Newsroom   /   Research News

Flexible Endoscope Manipulation Robot Finishes World's First Clinical Test in Digestive Tract Inspection

Jan 11, 2018     Email"> PrintText Size

Inside the operation room of Chinese PLA General Hospital, a patient was taking a digestive tract inspection. It was performed by a robot.  

It was the first clinical test of Flexible Endoscope Manipulation Robot (FEMR) assisted digestive tract intervention in the world, which was jointly carried out by researchers from Shenyang Institute of Automation of Chinese Academy of Sciences (SIACAS) and Chinese PLA General Hospital (PLAGH) on December 20, 2017. Professor YANG Yunsheng, Chairman of digestive disease branch, Chinese Medical Association, manipulated the robot and realized the inspection along the upper digestive tract. 

Developed by a research team led by LIU Hao, a researcher from SIACAS, FEMR has changed the traditional mode of endoscopic operation fundamentally. “It spares the doctors’ effort of standing beside patients while holding the endoscope; they can only operate the joysticks to complete the clinical operation.” LIU said.  

FEMR has passed the General Safety Test (GB 9706.1) and EMC Test (YY0505). It employed a series of ergonomics such as double arm configuration, Intuitionistic mapping and integrated irrigation and suction system to achieve accurate and safety operation of soft endoscope which is obviously superior to the traditional operation in the multi degree of freedom coordination operation and the quantitative display of operating parameters. 

At present, DaVinci surgical robot had great achievements and comprehensive monopoly in thoracic and abdominal minimally invasive surgery, but incapable for diagnosis and treatment in intracavities such as digestive, urinary and respiratory system. As a breakthrough in the field of surgical robot, the development of FEMR has great potential in clinical application. 


FEMR was performing operation. (Image by SIA) 


(Editor: LIU Jia)



Related Articles

MOU;nose cancer;cancer;clinical test

HK, Australia Scientists to Start 2nd Phase Nose Cancer Therapy Clinical Test

Aug 31, 2015

Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU) and QIMR Berghofer Medical Research Institute (QIMR Berghofer) of Queensland, Australia signed here Friday a Memorandum of Understanding to mark the continuous collaboration of an inn...

Contact Us

Copyright © 2002 - Chinese Academy of Sciences